TearScience Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 73

Employees

  • Latest Deal Type
  • M&A

TearScience General Information

Description

Developer of medical devices designed to diagnose the leading cause of dry eye. The company's medical devices involves in identifying, diagnosing and treating Meibomian Gland Dysfunction (MGD), the leading cause of dry eye, with an FDA-cleared liquid that restores gland function, enabling patients to begin treatment more quickly and result in a higher likelihood of a successful treatment to improve gland function and alleviate symptoms.

Contact Information

Website
www.tearscience.com
Formerly Known As
Kolis Scientific, Kolis Scientific Inc
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 5151 McCrimmon Parkway
  • Suite 250
  • Morrisville, NC 27560
  • United States
+1 (919)
Primary Industry
Diagnostic Equipment
Acquirer
Johnson & Johnson Vision Care
Corporate Office
  • 5151 McCrimmon Parkway
  • Suite 250
  • Morrisville, NC 27560
  • United States
+1 (919)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TearScience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 06-Sep-2017 Completed Generating Revenue
6. Later Stage VC (Series D) 12-Apr-2016 Completed Generating Revenue
5. Later Stage VC 26-Feb-2013 Completed Generating Revenue
4. Debt - General 03-Oct-2011 Completed Generating Revenue
3. Later Stage VC (Series C) 05-May-2010 Completed Generating Revenue
2. Early Stage VC (Series B) 17-Jan-2007 $15.4M $17.6M Completed Startup
1. Early Stage VC (Series A) 20-Jun-2005 $2.2M $2.2M Completed Startup
To view TearScience’s complete valuation and funding history, request access »

TearScience Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C
Series B
Series A 2,200,000 $0.000100 $0.08 $1 $1 1x $1 6.49%
To view TearScience’s complete cap table history, request access »

TearScience Patents

  • 239

    Total Documents Applications and Grants

  • Total Patents Families

  • 147

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

TearScience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2015073664-A2 Apparatuses and methods for detecting lid margin contact and blink rates, particularly for diagnosing, measuring, and/or analyzing dry eye conditions and symptoms Inactive 15-Nov-2013
WO-2015073664-A3 Apparatuses and methods for detecting lid margin contact and blink rates, particularly for diagnosing, measuring, and/or analyzing dry eye conditions and symptoms Inactive 15-Nov-2013
US-20150138504-A1 Ocular tear film peak detection and stabilitzation detection systems and methods for determining tear film layer characteristics Active 15-Nov-2013
WO-2015073986-A1 Ocular tear film peak detection and stabilitzation detection systems and methods for determining tear film layer characteristics Inactive 15-Nov-2013
US-10512396-B2 Ocular tear film peak detection and stabilization detection systems and methods for determining tear film layer characteristics Active 15-Nov-2013 A61B3/101
To view TearScience’s complete patent history, request access »

TearScience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TearScience Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
De Novo Ventures Venture Capital Minority
EW Healthcare Partners Growth/Expansion Minority
General Catalyst Venture Capital Minority
HCRx PE/Buyout Minority
Patricia Industries PE/Buyout Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

TearScience FAQs

  • When was TearScience founded?

    TearScience was founded in 2005.

  • Where is TearScience headquartered?

    TearScience is headquartered in Morrisville, NC.

  • What is the size of TearScience?

    TearScience has 73 total employees.

  • What industry is TearScience in?

    TearScience’s primary industry is Diagnostic Equipment.

  • Is TearScience a private or public company?

    TearScience is a Private company.

  • What is TearScience’s current revenue?

    The current revenue for TearScience is .

  • How much funding has TearScience raised over time?

    TearScience has raised $216M.

  • Who are TearScience’s investors?

    De Novo Ventures, EW Healthcare Partners, General Catalyst, HCRx, and Patricia Industries are 5 of 7 investors who have invested in TearScience.

  • When was TearScience acquired?

    TearScience was acquired on 06-Sep-2017.

  • Who acquired TearScience?

    TearScience was acquired by Johnson & Johnson Vision Care.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process